Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rein Therapeutics Inc.

    NASDAQ: RNTX · Real-Time Price · USD
    1.84
    -0.04 (-2.13%)
    At close: Jun 16, 2025, 3:59 PM
    1.82
    -1.09%
    After-hours: Jun 16, 2025, 04:04 PM EDT

    Rein Therapeutics Statistics

    Share Statistics

    Rein Therapeutics has 22.15M shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 22.15M

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 192

    FTD / Avg. Volume

    n/a
    		 0.54%

    Short Selling Information

    The latest short interest is 86.47K, so 0.39% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 86.47K

    Short % of Shares Out

    n/a
    		 0.39%

    Short % of Float

    n/a
    		 0.39%

    Short Ratio (days to cover)

    n/a
    		 2.59

    Valuation Ratios

    PE Ratio

    n/a
    		 0

    Forward PE

    n/a
    		 -3.56

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 0

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Rein Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.38, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 2.38

    Quick Ratio

    n/a
    		 2.38

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-5,716,636.36

    Employee Count

    n/a
    		 11

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.54M

    Effective Tax Rate

    n/a
    		 2.4%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 1.31, so Rein Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.31

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 1.85

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 42.48

    Average Volume (20 Days)

    n/a
    		 35,400

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -65.11M

    Net Income

    n/a
    		 -62.88M

    EBITDA

    n/a
    		 -28.05M

    EBIT

    n/a
    		 -28.11M

    Earnings Per Share (EPS)

    n/a
    		 -3.51
    Full Income Statement

    Balance Sheet

    The company has 12.87M in cash and 0 in debt, giving a net cash position of 12.87M.

    Cash & Cash Equivalents

    n/a
    		 12.87M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -351.4M

    Total Assets

    n/a
    		 62.19M

    Working Capital

    n/a
    		 7.91M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -22.29M and capital expenditures 0, giving a free cash flow of -22.29M.

    Operating Cash Flow

    n/a
    		 -22.29M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -22.29M

    FCF Per Share

    n/a
    		 -1242.67
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    RNTX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for RNTX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 11, 2022. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Nov 11, 2022

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -4.76

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist